Deep Orbital Sub-Q Hyaluronic Acid Filler Injection for Enophthalmic Sighted Eyes in Parry-Romberg Syndrome
Feldman I., Sheptulin V. A., Grusha Ya. O., Malhotra R.
Ophthalmic Plastic and Reconstructive Surgery
Vol.34, Issue5, P. 449-451
Опубликовано: 2018
Тип ресурса: Статья
DOI:10.1097/IOP.0000000000001050
Аннотация:
PURPOSE: The authors present a consecutive series of deep orbital Sub-Q injections to treat enophthalmic sighted eyes in Parry-Romberg syndrome patients.METHODS: Retrospective, interventional case series in 2 centers. Data were collected on patient demographics, Parry-Romberg syndrome onset age, previous orbital and eyelid surgeries, diplopia, ocular movement restriction before and after the injection, number of injections, interval between injections, indication for any top-up or dissolution of filler, and any other complications. In all cases, the hyaluronic acid gel used was Restylane Sub-Q + Lidocaine.RESULTS: A total of 8 injections on 3 patients with Parry-Romberg syndrome, and significant enophthalmos is reported. All injections were with deep orbital Sub-Q filler. All patients were females, aged 32, 24, and 52 years old while their symptoms started at 15, 16, and 30 years old, respectively. None had orbital surgery prior to the injection. Follow up period was 2, 7, and 5 years
Ключевые слова:
hyaluronic acid; viscosupplement; adult; clinical trial; complication; enophthalmos; female; follow up; hemifacial atrophy; human; middle aged; multicenter study; retrospective study; Adult; Enophthalmos; Facial Hemiatrophy; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Middle Aged; Retrospective Studies; Viscosupplements
Язык текста: Английский
ISSN: 1537-2677
Feldman I.
Sheptulin V. A.
Grusha Ya. O. Yaroslav Olegovich 1968-
Malhotra R.
Фелдман И.
Шептюлин В. А.
Груша Я. О. Ярослав Олегович 1968-
Малхотра Р.
Deep Orbital Sub-Q Hyaluronic Acid Filler Injection for Enophthalmic Sighted Eyes in Parry-Romberg Syndrome
Текст визуальный непосредственный
Ophthalmic Plastic and Reconstructive Surgery
Lippincott Williams & Wilkins
Vol.34, Issue5 P. 449-451
2018
Статья
hyaluronic acid viscosupplement adult clinical trial complication enophthalmos female follow up hemifacial atrophy human middle aged multicenter study retrospective study Adult Enophthalmos Facial Hemiatrophy Female Follow-Up Studies Humans Hyaluronic Acid Middle Aged Retrospective Studies Viscosupplements
PURPOSE: The authors present a consecutive series of deep orbital Sub-Q injections to treat enophthalmic sighted eyes in Parry-Romberg syndrome patients.METHODS: Retrospective, interventional case series in 2 centers. Data were collected on patient demographics, Parry-Romberg syndrome onset age, previous orbital and eyelid surgeries, diplopia, ocular movement restriction before and after the injection, number of injections, interval between injections, indication for any top-up or dissolution of filler, and any other complications. In all cases, the hyaluronic acid gel used was Restylane Sub-Q + Lidocaine.RESULTS: A total of 8 injections on 3 patients with Parry-Romberg syndrome, and significant enophthalmos is reported. All injections were with deep orbital Sub-Q filler. All patients were females, aged 32, 24, and 52 years old while their symptoms started at 15, 16, and 30 years old, respectively. None had orbital surgery prior to the injection. Follow up period was 2, 7, and 5 years